Download the Free Prime PubMed App to your smartphone or tablet.

Available for iPhone or iPad:

Unbound PubMed app for iOS iPhone iPadAlso Available:
Unbound PubMed app for Android

Available for Mac and Windows Desktops and laptops:

Unbound PubMed app for Windows
(Micardis HCT 40 12 5)
8 results
  • Telmisartan/hydrochlorothiazide combination therapy in the treatment of essential hypertension. [Review]
    Expert Opin Pharmacother 2004; 5(11):2303-10Schmieder RE
  • Telmisartan is an angiotensin-II receptor blocker that has demonstrated efficacy in the reduction of blood pressure in patients with hypertension. Patients with hypertension commonly require two or more antihypertensives to reduce their blood pressure to safe levels, and the choice of combination therapy should be informed by clinical trial data. Telmisartan is available in fixed-dose combination…
  • Telmisartan/hydrochlorothiazide: in the treatment of essential hypertension. [Review]
    Drugs 2003; 63(19):2013-26; discussion 2027-8Fenton C, Keating GM, Scott LJ
  • Oral telmisartan/hydrochlorothiazide (HCTZ) combines two antihypertensive agents, a selective angiotensin II receptor antagonist with a long half-life and once-daily administration, and a thiazide diuretic. In two large, 8-week, double-blind trials, patients with hypertension unresponsive to monotherapy who received combined telmisartan/HCTZ 80/12.5 or 40/12.5 mg/day, achieved significantly large…
New Search